NBIX
NASDAQ · Biotechnology
Neurocrine Biosciences Inc
$139.49
-2.76 (-1.94%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-4.90%
YTD
-0.79%
Open$141.97
Previous Close$142.25
Day High$142.25
Day Low$139.32
52W High$186.12
52W Low$122.14
Volume—
Avg Volume966.1K
Market Cap15.43B
P/E Ratio21.88
EPS$6.82
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$139.44
Above
SMA 200
$135.94
Above
RSI (14)
38.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
36 analysts
Price Target
-9.0% upside
Current
$139.49
$139.49
Target
$126.93
$126.93
$104.30
$126.93 avg
$177.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.95B | 2.37B | 5.53B |
| Net Income | 492.81M | 356.76M | 497.45M |
| Profit Margin | 16.7% | 15.9% | 9.0% |
| EBITDA | 664.25M | 507.59M | 909.27M |
| Free Cash Flow | — | — | 422.12M |
| Rev Growth | +24.3% | +24.3% | -8.7% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.08 | -0.05% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.09 | -1.01% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.37 | -0.85% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $516.34 | +0.26% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $801.82 | -0.26% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.51 | -2.04% | 40.0 | 32.33B |